Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
14. May 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8911
Articles 1 - 20 / 178210
Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities.
Br J Cancer
Waldron NR, Silva D, Westaby D, Jiménez-Vacas J, Taylor J, Sharp A.
PMID: 42129337 [PubMed - as supplied by publisher]
Diabetes mellitus and health-related quality of life in long-term survivors of breast, colorectal or prostate cancer: a population-based prospective study.
Br J Cancer
Yang K, Thong MSY, Doege D, Koch-Gallenkamp L, Weisser L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Jansen L, Brenner H, Arndt V.
PMID: 42129336 [PubMed - as supplied by publisher]
Imaging-based clinical decision tree enables risk stratification of extraprostatic extension before radical prostatectomy in prostate cancer patients.
Insights Imaging
Hamm CA, Rüterhenke T, Baumgärtner GL, Mayerosch C, Schallenberg S, Lindholz M, Beetz NL, Asbach P, Penzkofer T.
PMID: 42129021 [PubMed]
Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancer.
World J Urol
Cournède M, Gabriel PE, Lottin M, Moschini M, Soria F, D'Andrea D, Shariat SF, Budowski A, Poyet C, Roumiguie M, Alvarez-Maestro M, Briganti A, Krajewski W, Hendricksen K, Veerman H, Afferi L, Mattei A, Di Bona C, Zamboni S, Simeone C, Thenault R, Verhoest G, Gontero P, Xylinas E.
PMID: 42128947 [PubMed - indexed for MEDLINE]
Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials.
Eur Urol Oncol
Tan WS, Kamat AM, Lewis R, Porta N, Ackerman C, Vadiveloo T, Penegar S, Martini A, Vale L, Mostafid H, MacLennan G, Hall E, Heer R, Kelly JD.
PMID: 42128773 [PubMed - as supplied by publisher]
Salivary and serum microRNAs as noninvasive biomarkers for distinguishing prostate cancer from benign prostatic hyperplasia.
Am J Clin Pathol
Salehi M, Alaee M, Mousavi M, Panahi G, Goodarzi D, Amri J.
PMID: 42128534 [PubMed - indexed for MEDLINE]
First-in-human single-cell and TCR atlas reveals peripheral immune remodeling before and after irreversible electroporation in prostate cancer.
J Immunother Cancer
Xiang JC, Xia ZY, Sun JX, Ye GC, Wang Y, Yang J, Wang SG, Xia QD.
PMID: 42128518 [PubMed - indexed for MEDLINE]
Paraganglioma of the urinary bladder with a novel variant of SDHB mutation.
BMJ Case Rep
Shivani ZA, Puthalath RT.
PMID: 42128441 [PubMed - indexed for MEDLINE]
Nectin4-targeted molecular imaging for precise endoscopic diagnosis and image-guided surgery in bladder cancer.
Cell Rep Med
He Y, Guo H, Wang B, Gao W, Deng Y, Zhao Y, He K, Liang X, Tian J, Wang J, Li X, Du Y.
PMID: 42127904 [PubMed - as supplied by publisher]
Linguistic explicitness and lay‑adapted translation in health communication: A randomized controlled trial of prostate cancer screening communication among elderly Chinese males.
Patient Educ Couns
Shan Y, Ji M, Xu X, Xing Z, Dong Z.
PMID: 42127712 [PubMed - as supplied by publisher]
Semen RNA-Based Biomarkers for Prostate Cancer Detection and Risk Stratification: A Prospective Multi-Center Validation Study.
J Urol
Whitney DH, Clay M, Wipperfurth J, Wylie D, Shore ND, D'Anna R, Saltzstein D, Little K, Nabian M, Hovelson DH, Breunig E, Brawer M, Tyra L, Zutz T, Jarrard D.
PMID: 42127322 [PubMed - as supplied by publisher]
Correction: Berezowski et al. Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation Study. Cancers 2025, 17, 2588.
Cancers (Basel)
Berezowski B, Boothe R Jr, Chaplin B, Del Vecchio SJ, Fares Z, Humphries TLR, Ng KL, Noonan T, Samaratunga H, Urquhart A, Vesey DA, Wood ST, Gobe GC, Ellis RJ.
PMID: 42126826 [PubMed]
MRI radiomics predicting cribriform growth informs active surveillance decision in intermediate-risk prostate cancer.
Eur Radiol Exp
Fernandez Salamanca M, Simões R, Der, Pais Pooch E, van Leeuwen PJ, van der Poel HG, Guimaraes MAS, van der Heide UA, Schoots IG.
PMID: 42126787 [PubMed - indexed for MEDLINE]
NeuroSAFE-guided robot-assisted radical prostatectomy versus standard RARP: systematic review and meta-analysis of comparative studies.
J Robot Surg
Suartz CV, Micheleto JPC, Condotta BE, Schumacher LB, Galhardo KA, Azevedo MFD, Brito PHS, Chade D, Mota JM, Dener MC, Talizin TB, Sharour W, Shabana W, Lopes RI, Wettstein M, Elkoushy M, Nahas WC, Melão BVLA, de Almeida Luz M, Reis LO, de Bessa Junior J, De Carvalho Fernandes R, Filho LAR.
PMID: 42126466 [PubMed - indexed for MEDLINE]
Robot-Assisted Radical Prostatectomy Using the KangDuo-SR-2000: A Prospective, Multicenter, Single-Arm Clinical Study.
Int J Med Robot
Tao Z, Zhang Z, Wang Z, Fan S, Chen X, Li Z, Chen S, Li X, Yang K, Li C, Li D, Xu Y, Xu T, Li J, Wang H, Wang B, Liu R, Zhang X, Zhang M, Gao Z, Zhang Z, Hao H, Yao L, Zhang K, Gu Y, Zhou L, Xu W, Shen C, Li X.
PMID: 42126008 [PubMed - indexed for MEDLINE]
Immune-inflammation index as prognostic markers in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
Front Oncol
Qin Z, Liu R, Jing S, Guo C, Li W.
PMID: 42125686 [PubMed]
Adjuvant therapy for renal cell carcinoma: lessons from past failures and new opportunities in the era of immune checkpoint inhibition.
Front Immunol
Liu Z, Cong X, Liu Z, Yin J, Chen C, Liu Z.
PMID: 42125664 [PubMed - indexed for MEDLINE]
Lipidomic Plasticity in Testicular Cancer Reflects Diagnostic Signatures in Tissue and Plasma: A Pilot Study.
Andrology
Nobre I, Ferreira HB, Domingues P, Guerra IMS, Pinho M, Melo T, Almeida RG, Sousa V, Quaresma V, da Silva ET, Oliveira PF, Paiva A, Domingues MR.
PMID: 42124466 [PubMed - as supplied by publisher]
The Prognostic Value of Tumor HER2 Expression in Predicting Oncological Outcomes of Patients with Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Int J Mol Sci
Alibeiginejad MH, Esmaielpour A, Tsuboi I, Matsukawa A, Yanagisawa T, Mori K, Kardoust Parizi M.
PMID: 42123709 [PubMed - indexed for MEDLINE]
Genetic and Epigenetic Drivers of Wilms Tumor Predisposition in Russian Pediatric Patients: A Multicenter Study.
Int J Mol Sci
Semenova V, Sagoyan G, Zhukovskaya E, Kozlova V, Gegelia N, Mitrofanova A, Suleymanova A, Druy A, Zelenova E, Pavlov V, Rubanskay M, Karelin A, Varfolomeeva S, Nasedkina T.
PMID: 42123644 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 178210
Page 1 of 8911
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy